Organon & Co. (OGN)
13.64
+0.01
(+0.07%)
USD |
NYSE |
Sep 11, 16:00
13.64
0.00 (0.00%)
After-Hours: 20:00
Organon Net Income (Quarterly) : 108.00M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 108.00M |
| March 31, 2026 | 146.00M |
| December 31, 2025 | -205.00M |
| September 30, 2025 | 160.00M |
| June 30, 2025 | 145.00M |
| March 31, 2025 | 87.00M |
| December 31, 2024 | 109.00M |
| September 30, 2024 | 359.00M |
| June 30, 2024 | 195.00M |
| March 31, 2024 | 201.00M |
| December 31, 2023 | 546.00M |
| September 30, 2023 | 58.00M |
| June 30, 2023 | 242.00M |
| Date | Value |
|---|---|
| March 31, 2023 | 177.00M |
| December 31, 2022 | 108.00M |
| September 30, 2022 | 227.00M |
| June 30, 2022 | 234.00M |
| March 31, 2022 | 348.00M |
| December 31, 2021 | 202.00M |
| September 30, 2021 | 323.00M |
| June 30, 2021 | 431.00M |
| March 31, 2021 | 395.00M |
| December 31, 2020 | 376.00M |
| September 30, 2020 | 560.00M |
| June 30, 2020 | 586.00M |
| March 31, 2020 | 734.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Merck & Co., Inc. | -1.337B |
| Eli Lilly & Co. | 7.095B |
| Pfizer Inc. | -246.00M |
| Bristol Myers Squibb Co. | 3.316B |
| Crinetics Pharmaceuticals, Inc. (DELISTED) | -120.86M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.558B |
| Total Expenses (Quarterly) | 1.45B |
| EPS Diluted (Quarterly) | 0.3993 |
| Enterprise Value | 11.00B |
| Gross Profit Margin (Quarterly) | 54.36% |
| Profit Margin (Quarterly) | 6.93% |
| Earnings Yield | 5.72% |
| Operating Earnings Yield | 33.08% |
| Normalized Earnings Yield | 11.10 |